Results 21 to 30 of about 7,967 (189)
Pembrolizumab on pre-existing inclusion body myositis: a case report
BMC Rheumatology, 2020 Background Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased ...
Naohiro Uchio +9 more
doaj +1 more source
Inclusion body myositis: Update on the diagnostic and therapeutic landscape
Frontiers in Neurology, 2022 Inclusion body myositis (IBM) is a progressive muscle disease affecting patients over the age of 40, with distinctive clinical and histopathological features. The typical clinical phenotype is characterized by prominent involvement of deep finger flexors
Elie Naddaf
doaj +1 more source
Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
Biomolecules, 2019 The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy. Its complex pathogenesis includes degenerative, inflammatory and mitochondrial aspects.
Boel De Paepe
doaj +1 more source
Polymyositis and dermatomyositis: Disease spectrum and classification
Indian Journal of Dermatology, 2012 Muscle inflammation and weakness are the key features of idiopathic inflammatory myopathies (IIMs). In addition IIMs are frequently associated with cutaneous and pulmonary involvement. In clinical practice the three common inflammatory myopathies we come
Siba P Raychaudhuri, Anupam Mitra
doaj +1 more source
Inclusion-Body Myositis Associated with Alzheimer’s Disease
Case Reports in Medicine, 2013 Sporadic inclusion-body myositis (s-IBM) is a myopathy that is characterized by progressive weakness and muscle pathology demonstrating inflammation and rimmed vacuoles.
Danijela Levacic +4 more
doaj +1 more source
Inclusion body myositis – pathomechanism and lessons from genetics
Open Medicine, 2015 Inclusion body myositis is a rare, late-onset myopathy. Both inflammatory and myodegenerative features play an important role in their pathogenesis.
Murnyák Balázs +8 more
doaj +1 more source
Cardiology Discovery. Previous studies have reported elevated cardiac troponin T (cTnT) in patients with inclusion body myositis due to skeletal myopathy. Although the trends of cTnT have been reported in some cases, the onset of elevation has barely been reported.
Zhiqing Fu, Xiujin Zhang, Hanjia Gao
doaj +1 more source
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
Frontiers in Immunology, 2019 Objective: Sporadic Inclusion Body Myositis (sIBM) is an inflammatory myopathy (IIM) without a specific diagnostic biomarker until autoantibodies to the cytosolic 5′-nucleotidase 1A (NT5c1A/Mup44) were reported.
Adam Amlani +11 more
doaj +1 more source
Update in inclusion body myositis [PDF]
Current Opinion in Rheumatology, 2013 The purpose of this study is to review recent scientific advances relating to the natural history, cause, treatment and serum and imaging biomarkers of inclusion body myositis (IBM).Several theories regarding the aetiopathogenesis of IBM are being explored and new therapeutic approaches are being investigated. New diagnostic criteria have been proposed,
Machado, P, Brady, S, Hanna, MG
openaire +3 more sources
Arthritis Care &Research, EarlyView.Objective Somatic items used in depression assessments can potentially overlap with symptoms related to physical illness, including systemic sclerosis (SSc). No studies have looked at whether somatic depression items may be influenced by diffuse versus limited SSc disease subtypes, which are associated with varying degrees of symptom presentation.
Sophie Hu +110 more
wiley +1 more source